Abbott IMx evaluated for assay of prostate-specific antigen in serum

• Published in: Clinical chemistry (Baltimore, Md.) Vol. 38; no. 10; pp. 2140 - 2142
• Main Authors: Dnistrian, AM, Schwartz, MK, Smith, CA, Nisselbaum, JS, Fair, WR
• Format: Journal Article
• Language: English
• Published: Washington, DC Am Assoc Clin Chem 01.10.1992; American Association for Clinical Chemistry
• Subjects: Autoanalysis; Biological and medical sciences; Humans; Immunoenzyme Techniques - standards; Immunoenzyme Techniques - statistics & numerical data; Male; Medical sciences; Nephrology. Urinary tract diseases; Prostate-Specific Antigen - blood; Reagent Kits, Diagnostic - standards; Reagent Kits, Diagnostic - statistics & numerical data; Urinary system involvement in other diseases. Miscellaneous; Urinary tract. Prostate gland; Human; Urinary system disease; Tumor associated antigen; Radioimmunoassay; Exploration; Serum; Tumoral marker; Malignant tumor; Enzyme immunoassay; Prostatic disease; Comparative study; Quantitative analysis

We evaluated a new fully automated procedure for quantitative measurement of prostate-specific antigen (PSA) by the Microparticle Enzyme Immunoassay (MEIA) technology developed for the Abbott IMx automated immunoassay system. The performance characteristics of the Abbott IMx PSA assay (y) were evalu...